Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV

Abroad (travel likely)RecruitingPHASE2

Conditions

Major Depressive Disorder · Anxiety Depression · HIV

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Shibani Mukerji, MD, PhD)

Study leads

Shibani S. Mukerji, MD, PhD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Depression · Major Depressive Disorder · Major Depression

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

tDCS: Sleep to Mood in Depression (S2M-D)

Major Depressive Disorder · MDD · Depression

Abroad (travel likely)Recruiting

New York, United States

AtWork: The Relation Between Cognitive Functioning, Common Mental Disorders and Work Functioning

Depression - Major Depressive Disorder · Anxiety

Abroad (travel likely)Recruiting

Oslo, Norway

A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression

Major Depressive Disorder (MDD)

Abroad (travel likely)RecruitingPHASE2

Bentonville, United States · Little Rock, United States